Skip to main navigation
Athenex
Improving the lives of cancer patients everywhere
About
About Athenex
Our Team
Leadership
Board of Directors
Our Operations
Our Partnerships
Contact
Pipeline
Science
Technology Platform
Cell Therapy
Orascovery
Src Kinase Inhibition
Publications & Presentations
Investors
Overview
News & Events
Press Releases
Events & Presentations
Financial Information
SEC Filings
Annual Meeting Materials
Special Meeting Materials
Annual Reports
Quarterly Results
Corporate Governance
Governance Highlights
Committee Composition
Analyst Coverage
Stock Information
Stock Quote & Chart
Historical Price Lookup
Investment Calculator
Investor Resources
Investor FAQs
Information Request
E-mail Alerts
IR Contacts
Careers
Menu
back
IR Contacts
IR Contacts
General Investor Inquiries:
Email:
ir@athenex.com
Tel: +1 716-427-2952
sidebar nav
Overview
News & Events
Press Releases
Events & Presentations
Financial Information
SEC Filings
Annual Meeting Materials
Annual Reports
Quarterly Results
Corporate Governance
Governance Highlights
Committee Composition
Analyst Coverage
Stock Information
Historical Price Lookup
Investment Calculator
Investor Resources
Investor FAQs
Information Request
E-mail Alerts
IR Contacts
Print Page
RSS
E-mail Alerts
